Enlivex Historical Valuation

ENLV Stock  USD 1.13  0.02  1.74%   
Some fundamental drivers such as market cap or Enlivex Therapeutics enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Enlivex Therapeutics valuation indicators such as Enterprise Value of 41.9 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Enlivex Therapeutics's future value.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enlivex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Enlivex Stock please use our How to Invest in Enlivex Therapeutics guide.

About Enlivex Valuation Data Analysis

Valuation is the financial process of determining what Enlivex Therapeutics is worth. Enlivex Therapeutics valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Enlivex Therapeutics valuation ratios help investors to determine whether Enlivex Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Enlivex with respect to the benefits of owning Enlivex Therapeutics security.

Enlivex Therapeutics Valuation Data Chart

Market Cap is likely to climb to about 50.2 M in 2025, whereas Enterprise Value is likely to drop slightly above 41.9 M in 2025.

Enterprise Value

Enterprise Value (or EV) is usually referred to as Enlivex Therapeutics theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Enlivex Therapeutics debt, but would also pocket its cash. Enterprise Value is more accurate representation of Enlivex Therapeutics value than its market capitalization because it takes into account all of Enlivex Therapeutics existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Enlivex Stock Analysis

When running Enlivex Therapeutics' price analysis, check to measure Enlivex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enlivex Therapeutics is operating at the current time. Most of Enlivex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Enlivex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enlivex Therapeutics' price. Additionally, you may evaluate how the addition of Enlivex Therapeutics to your portfolios can decrease your overall portfolio volatility.